Max Fehlmann

Max Fehlmann is the founder of two companies.
The Consortium Québécois sur la Découverte du Médicament was founded in 2008, and NEOMED-LABS, Inc. was founded in 2015.
At the Consortium Québécois sur la Découverte du Médicament, he holds the title of Director from 2008 to present.
At NEOMED-LABS, Inc., he held the title of Director from 2015 to 2017.
Dr. Fehlmann's current job is President & Chief Executive Officer at the Cancer Research Society, which he started in 2017.
Dr. Fehlmann's former jobs include President & Chief Executive Officer at Chronogen, Inc. from 2004 to 2010, Director-Research & Development at Zambon Company SpA from 1996 to 2003, and Principal at Institut National de la Santé & de la Recherche Médicale.
He was also President & Scientific Director at Institut de recherches cliniques de Montréal and Director at Neomed Institute.
Dr. Fehlmann received a doctorate degree from Université Laval.